GTHP (Guided Therapeutics) Insider Ownership: 39.88 % (As of Aug. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GTHP Guided Therapeutics Inc GTHP
22 GF Score
Price $0.29
! 4 Warning Signs
View Full Analysis

What is Guided Therapeutics Insider Ownership?

Guided Therapeutics GTHP 22 Insider Ownership is 39.88 % as of Aug. 14, 2026. GuruFocus rates GTHP with a GF Score™ of 22/100. The stock has 4 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Guided Therapeutics's insider ownership is 39.88%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Guided Therapeutics's Institutional Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Guided Therapeutics's Float Percentage Of Total Shares Outstanding is 65.21%.

Guided Therapeutics Insider Ownership Historical Data

* Premium members only.

The historical data trend for Guided Therapeutics's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guided Therapeutics Insider Ownership Chart

Guided Therapeutics Historical Data

The historical data trend for Guided Therapeutics can be seen below:

2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31
Insider Ownership 39.24 38.57 42.43 42.43 42.43 40.75 40.75 39.88 39.88 39.88
GTHP
22GF Score
Guided Therapeutics Inc GTHP
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guided Therapeutics Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 39.88 % mean?
Guided Therapeutics (GTHP) has a Insider Ownership of 39.88 % as of Aug. 14, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Guided Therapeutics and its competitors.
Is Guided Therapeutics' Insider Ownership too high?
Guided Therapeutics' current Insider Ownership is 39.88 %. Overall, Guided Therapeutics has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Guided Therapeutics' Insider Ownership compare to PETV and FOFA?
Guided Therapeutics' Insider Ownership of 39.88 % can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Medical Devices & Instruments company?
A good Insider Ownership depends on the Medical Devices & Instruments industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Guided Therapeutics and its competitors. Guided Therapeutics's current Insider Ownership is 39.88 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guided Therapeutics stock overvalued right now?
Guided Therapeutics (GTHP) has a current Insider Ownership of 39.88 %. The current Insider Ownership is 39.88 %. Guided Therapeutics' overall GF Score™ is 22/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Guided Therapeutics (GTHP), the current Insider Ownership is 39.88 % as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Guided Therapeutics Business Description

Address 5835 Peachtree Corners East, Suite B, Peachtree Corners, GA, USA, 30092
Guided Therapeutics Inc is a medical technology company. It is engaged in developing medical devices that have the potential to improve healthcare. Its primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device and the extension of its cancer detection technology into other cancers, including esophageal. The company generates revenue from the sale of medical devices.
22GF Score

Get the complete analysis for GTHP

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.29
Price